Matches in SemOpenAlex for { <https://semopenalex.org/work/W3143752425> ?p ?o ?g. }
- W3143752425 endingPage "703" @default.
- W3143752425 startingPage "694" @default.
- W3143752425 abstract "Preferentially expressed antigen in melanoma (PRAME) is a cancer/testis antigen that is overexpressed in many human malignancies and poorly expressed or absent in healthy tissues, making it a good target for anti-cancer immunotherapy. Development of an effective off-the-shelf adoptive T-cell therapy for patients with relapsed or refractory solid tumors and hematological malignancies expressing PRAME antigen requires the identification of major histocompatibility complex (MHC) class I and II PRAME antigens recognized by the tumor-associated antigen (TAA) T-cell product. The authors therefore set out to extend the repertoire of HLA-restricted PRAME peptide epitopes beyond the few already characterized.Peptide libraries of 125 overlapping 15-mer peptides spanning the entire PRAME protein sequence were used to identify HLA class I- and II-restricted epitopes. The authors also determined the HLA restriction of the identified epitopes.PRAME-specific T-cell products were successfully generated from peripheral blood mononuclear cells of 12 healthy donors. Ex vivo-expanded T cells were polyclonal, consisting of both CD4+ and CD8+ T cells, which elicited anti-tumor activity in vitro. Nine MHC class I-restricted PRAME epitopes were identified (seven novel and two previously described). The authors also characterized 16 individual 15-mer peptide sequences confirmed as CD4-restricted epitopes.TAA T cells derived from healthy donors recognize a broad range of CD4+ and CD8+ HLA-restricted PRAME epitopes, which could be used to select suitable donors for generating off-the-shelf TAA-specific T cells." @default.
- W3143752425 created "2021-04-13" @default.
- W3143752425 creator A5007455653 @default.
- W3143752425 creator A5017322945 @default.
- W3143752425 creator A5033997937 @default.
- W3143752425 creator A5038746962 @default.
- W3143752425 creator A5042431577 @default.
- W3143752425 creator A5049066393 @default.
- W3143752425 creator A5055159427 @default.
- W3143752425 creator A5055376125 @default.
- W3143752425 creator A5058071497 @default.
- W3143752425 creator A5060183118 @default.
- W3143752425 creator A5066139971 @default.
- W3143752425 creator A5077132028 @default.
- W3143752425 creator A5083853357 @default.
- W3143752425 creator A5085372074 @default.
- W3143752425 date "2021-08-01" @default.
- W3143752425 modified "2023-09-27" @default.
- W3143752425 title "Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies" @default.
- W3143752425 cites W1678167583 @default.
- W3143752425 cites W1968948384 @default.
- W3143752425 cites W1971826820 @default.
- W3143752425 cites W1973683879 @default.
- W3143752425 cites W1979718003 @default.
- W3143752425 cites W1983062149 @default.
- W3143752425 cites W1993191461 @default.
- W3143752425 cites W2006436161 @default.
- W3143752425 cites W2014308267 @default.
- W3143752425 cites W2019904910 @default.
- W3143752425 cites W2026134650 @default.
- W3143752425 cites W2029904828 @default.
- W3143752425 cites W2031196215 @default.
- W3143752425 cites W2033654955 @default.
- W3143752425 cites W2038413378 @default.
- W3143752425 cites W2057917996 @default.
- W3143752425 cites W2063609798 @default.
- W3143752425 cites W2066043065 @default.
- W3143752425 cites W2066311819 @default.
- W3143752425 cites W2066705769 @default.
- W3143752425 cites W2074520750 @default.
- W3143752425 cites W2082384238 @default.
- W3143752425 cites W2089408144 @default.
- W3143752425 cites W2098813484 @default.
- W3143752425 cites W2104342628 @default.
- W3143752425 cites W2105723991 @default.
- W3143752425 cites W2119036007 @default.
- W3143752425 cites W2122265109 @default.
- W3143752425 cites W2125685908 @default.
- W3143752425 cites W2129676200 @default.
- W3143752425 cites W2130817328 @default.
- W3143752425 cites W2132925083 @default.
- W3143752425 cites W2140341972 @default.
- W3143752425 cites W2140510830 @default.
- W3143752425 cites W2153549003 @default.
- W3143752425 cites W2340809593 @default.
- W3143752425 cites W2555695588 @default.
- W3143752425 cites W2744246163 @default.
- W3143752425 cites W2759087703 @default.
- W3143752425 cites W2759225097 @default.
- W3143752425 cites W2765431425 @default.
- W3143752425 cites W2800287139 @default.
- W3143752425 cites W2896066577 @default.
- W3143752425 cites W2910976963 @default.
- W3143752425 cites W2914774688 @default.
- W3143752425 cites W2964620721 @default.
- W3143752425 cites W2980950973 @default.
- W3143752425 cites W3000206567 @default.
- W3143752425 cites W3023639491 @default.
- W3143752425 doi "https://doi.org/10.1016/j.jcyt.2021.03.001" @default.
- W3143752425 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8316284" @default.
- W3143752425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33832817" @default.
- W3143752425 hasPublicationYear "2021" @default.
- W3143752425 type Work @default.
- W3143752425 sameAs 3143752425 @default.
- W3143752425 citedByCount "5" @default.
- W3143752425 countsByYear W31437524252021 @default.
- W3143752425 countsByYear W31437524252022 @default.
- W3143752425 countsByYear W31437524252023 @default.
- W3143752425 crossrefType "journal-article" @default.
- W3143752425 hasAuthorship W3143752425A5007455653 @default.
- W3143752425 hasAuthorship W3143752425A5017322945 @default.
- W3143752425 hasAuthorship W3143752425A5033997937 @default.
- W3143752425 hasAuthorship W3143752425A5038746962 @default.
- W3143752425 hasAuthorship W3143752425A5042431577 @default.
- W3143752425 hasAuthorship W3143752425A5049066393 @default.
- W3143752425 hasAuthorship W3143752425A5055159427 @default.
- W3143752425 hasAuthorship W3143752425A5055376125 @default.
- W3143752425 hasAuthorship W3143752425A5058071497 @default.
- W3143752425 hasAuthorship W3143752425A5060183118 @default.
- W3143752425 hasAuthorship W3143752425A5066139971 @default.
- W3143752425 hasAuthorship W3143752425A5077132028 @default.
- W3143752425 hasAuthorship W3143752425A5083853357 @default.
- W3143752425 hasAuthorship W3143752425A5085372074 @default.
- W3143752425 hasBestOaLocation W31437524252 @default.
- W3143752425 hasConcept C147483822 @default.
- W3143752425 hasConcept C154317977 @default.
- W3143752425 hasConcept C167672396 @default.
- W3143752425 hasConcept C188280979 @default.